New Delhi: The Ministry of AYUSH conferred the National Dhanwantari Ayurveda Awards 2025 on Prof Banwari Lal Gaur, Vaidya Neelakandhan Mooss ET., and Vaidya Bhavana Prasher, recognising their outstanding contributions…
Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) in combination with lurbinectedin (Zepzelca) for the maintenance treatment of…
Thiruvananthapuram: The Kerala Government Medical College Teachers Association (KGMCTA) has announced a statewide candlelight protest and sit-ins at all medical colleges at 6.30 p.m. on Friday to draw attention towards unresolved…
Muzaffarnagar: In a tragic incident, a gynaecologist who was travelling on a train to visit her hometown reportedly attempted suicide by slitting her wrist in the moving train on the…
Bhopal: In a shocking incident, multiple units of blood and plasma were reported stolen from the blood bank of the premier All India Institute of Medical Sciences (AIIMS) in Bhopal, police said…
New Delhi: The Bombay High Court has ruled in favour of Sun Pharma Laboratories Limited in its trademark infringement case against Fertilesure Pharma, restraining the Fertilesure Pharma from using marks…
Jaipur: The death of a five-year-old boy in Sikar district has raised serious concerns about the safety of a cough syrup manufactured by Kaysons Pharma, prompting the Rajasthan health department…
Basel: Novartis has announced that Rhapsido (remibrutinib) has received US Food and Drug Administration (FDA) approval as an oral treatment for adult patients with chronic spontaneous urticaria (CSU) who remain symptomatic…
Mumbai: In a move to strengthen cancer treatment, the Maharashtra cabinet on Tuesday approved a comprehensive cancer care policy. Under this initiative, the government will set up the Maharashtra Cancer…
New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to MSN Laboratories to conduct a Phase IV clinical trial of…